RESULTS	Of the 120 patients with COPD randomized ( men , 93.2 % ; mean age , 70.8 0.74 years ; prebronchodilator FEV , 53.9 2.0 % ; baseline characteristics comparable between treatment groups ) , 108 ( NAC , 52 ; placebo , 56 ) completed the 1-year study .\